A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
Public ClinicalTrials.gov record NCT00077623. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Controlled, Open-Label, Multi- Center, Parallel-Group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Subcutaneously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis
Study identification
- NCT ID
- NCT00077623
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Enrollment
- 572 participants
Conditions and interventions
Conditions
Interventions
- epoetin alfa or beta Drug
- methoxy polyethylene glycol-epoetin beta (Mircera) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 29, 2004
- Primary completion
- Aug 31, 2005
- Completion
- Aug 31, 2005
- Last update posted
- May 24, 2016
2004 – 2005
United States locations
- U.S. sites
- 17
- U.S. states
- 10
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Hot Springs | Arkansas | 71901 | — |
| Not listed | Los Angeles | California | 90033 | — |
| Not listed | Riverside | California | 92501 | — |
| Not listed | Sacramento | California | 95816-5119 | — |
| Not listed | San Jose | California | 95116-1906 | — |
| Not listed | Boston | Massachusetts | 02130 | — |
| Not listed | Springfield | Massachusetts | 01107 | — |
| Not listed | Detroit | Michigan | 48202-2689 | — |
| Not listed | Brooklyn Center | Minnesota | 55430 | — |
| Not listed | Raleigh | North Carolina | 27609 | — |
| Not listed | Winston-Salem | North Carolina | 27157-1023 | — |
| Not listed | Toledo | Ohio | 43606 | — |
| Not listed | Portland | Oregon | 97210 | — |
| Not listed | Dallas | Texas | 75216 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 73 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00077623, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 24, 2016 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00077623 live on ClinicalTrials.gov.